Drug combinations with methotrexate to treat rheumatoid arthritis
- PMID: 21044434
Drug combinations with methotrexate to treat rheumatoid arthritis
Abstract
MTX is still considered the anchor drug among the disease-modifying antirheumatic agents, and it is widely accepted as first line treatment in the management of rheumatoid arthritis (RA). The ultimate therapeutic goal in treatment of RA is remission or at least low disease activity and this goal may not always be achieved with MTX monotherapy. Over the last two decades drug combinations based on MTX have been used increasingly to treat patients with RA. Combination DMARD therapy may be used initially or in a step-up strategy after MTX monotherapy in patients with persistently active disease on monotherapy. Many different MTX based combination regimens have been studied. Frequently used combinations on an MTX background include leflunomide, cyclosporine, azathioprine, sulfasalazine, gold and hydroxychloroquine. In conclusion, the use of MTX in combination with other DMARDs may still represent a valuable therapeutic option in patients who fail to DMARD monotherapy or in whom combination therapy is considered initially. However, in patients at risk for rapid radiographic progression, the early use of biologics has to be considered.
Similar articles
-
Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry.Curr Med Res Opin. 2006 Jan;22(1):185-98. doi: 10.1185/030079905X65510. Curr Med Res Opin. 2006. PMID: 16393444
-
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18. Ann Rheum Dis. 2017. PMID: 27432356 Clinical Trial.
-
Remission in rheumatoid arthritis: wishful thinking or clinical reality?Semin Arthritis Rheum. 2005 Dec;35(3):185-96. doi: 10.1016/j.semarthrit.2005.06.003. Semin Arthritis Rheum. 2005. PMID: 16325659
-
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: A network meta-analysis.Cochrane Database Syst Rev. 2016 Aug 29;2016(8):CD010227. doi: 10.1002/14651858.CD010227.pub2. Cochrane Database Syst Rev. 2016. PMID: 27571502 Free PMC article. Review.
-
Update on methotrexate as the anchor drug for rheumatoid arthritis.Bull Hosp Jt Dis (2013). 2013;71 Suppl 1:S9-19. Bull Hosp Jt Dis (2013). 2013. PMID: 24219036 Review.
Cited by
-
EBV-positive B-cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency.Cancer Med. 2021 Oct;10(19):6777-6785. doi: 10.1002/cam4.4198. Epub 2021 Aug 13. Cancer Med. 2021. PMID: 34387382 Free PMC article. Review.
-
Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.Eur J Drug Metab Pharmacokinet. 2016 Aug;41(4):385-93. doi: 10.1007/s13318-015-0288-z. Eur J Drug Metab Pharmacokinet. 2016. PMID: 26077125
-
Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFα blocker failure.Biologics. 2012;6:191-9. doi: 10.2147/BTT.S32244. Epub 2012 Jul 2. Biologics. 2012. PMID: 22848150 Free PMC article.
-
Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.Dermatol Ther (Heidelb). 2014 Dec;4(2):145-56. doi: 10.1007/s13555-014-0056-z. Epub 2014 Jun 19. Dermatol Ther (Heidelb). 2014. PMID: 24942326 Free PMC article.
-
(1)H NMR-based metabolomic analysis for identifying serum biomarkers to evaluate methotrexate treatment in patients with early rheumatoid arthritis.Exp Ther Med. 2012 Jul;4(1):165-171. doi: 10.3892/etm.2012.567. Epub 2012 May 3. Exp Ther Med. 2012. PMID: 23060942 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical